Bediot, Ana .

HRN: 26-49-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
AMPICILLIN 1GM (VIAL)
05/16/2025
05/17/2025
IV
2g
Q6
Prom
Waiting Final Action 
05/17/2025
CEFUROXIME 500MG (TAB)
05/17/2025
05/23/2025
PO
500 Mg
BID
Urinary Tract Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: